Overview

This event is a complementary pre-event promotional webinar associated with the DIA 2024 Global Annual Meeting and open to the public.

Global access to cell and gene therapy (CGT) products is not just a goal; it's a necessity for patients worldwide. As the landscape of medicine rapidly evolves, these innovative therapies hold the potential to transform healthcare as we know it.

Delve deeper into this exciting field and explore the crucial aspects of CGT products during our upcoming webinar, Considerations to Support Global Regulatory Harmonization and Access of Cell and Gene Therapy Products to Patients.

Please also check out DIA’s 2024 Global Annual Meeting taking place June 16-20, 2024! Click here

Learning objectives

Identify the status of the ICH Cell and Gene Therapies Discussion Group (CGT DG) and opportunities for harmonization and regulatory reliance

Learn about current regulatory requirements for comparability for cell and gene therapy products and the challenges they present for this therapeutic modality

Identify unique clinical and non-clinical considerations for cell and gene therapy products

Have an account?

Considerations to Support Global Regulatory Harmonization and Access of Cell and Gene Therapy Products to Patients

Overview

Learning objectives

Be informed and stay engaged.